Bank of America Corp DE purchased a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 585,689 shares of the health services provider's stock, valued at approximately $31,487,000. Bank of America Corp DE owned 1.12% of Maximus at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of the business. Blue Trust Inc. increased its holdings in Maximus by 14.6% in the first quarter. Blue Trust Inc. now owns 1,321 shares of the health services provider's stock valued at $85,000 after purchasing an additional 168 shares during the last quarter. QRG Capital Management Inc. lifted its stake in Maximus by 9.3% in the first quarter. QRG Capital Management Inc. now owns 3,240 shares of the health services provider's stock valued at $208,000 after buying an additional 277 shares during the period. Sivia Capital Partners LLC boosted its holdings in Maximus by 14.1% during the fourth quarter. Sivia Capital Partners LLC now owns 3,308 shares of the health services provider's stock worth $286,000 after buying an additional 408 shares during the last quarter. Hantz Financial Services Inc. boosted its holdings in Maximus by 269.6% during the fourth quarter. Hantz Financial Services Inc. now owns 706 shares of the health services provider's stock worth $61,000 after buying an additional 515 shares during the last quarter. Finally, ProShare Advisors LLC grew its position in shares of Maximus by 4.4% during the 4th quarter. ProShare Advisors LLC now owns 12,617 shares of the health services provider's stock worth $1,089,000 after buying an additional 537 shares during the period. 97.21% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
MMS has been the subject of a number of recent analyst reports. Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Zacks Research lowered Maximus from a "hold" rating to a "strong sell" rating in a report on Tuesday, August 11th. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of Maximus in a research note on Monday, August 17th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Reduce".
Check Out Our Latest Analysis on Maximus
Maximus Price Performance
MMS stock opened at $55.33 on Wednesday. The stock has a 50-day moving average price of $58.12 and a two-hundred day moving average price of $61.43. The stock has a market cap of $2.90 billion, a PE ratio of 8.17 and a beta of 0.59. The company has a current ratio of 2.42, a quick ratio of 2.42 and a debt-to-equity ratio of 0.90. Maximus, Inc. has a 1 year low of $52.73 and a 1 year high of $100.00.
Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, topping the consensus estimate of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The company had revenue of $1.28 billion during the quarter, compared to analysts' expectations of $1.33 billion. During the same period in the prior year, the firm earned $2.16 earnings per share. Maximus's revenue for the quarter was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Equities analysts forecast that Maximus, Inc. will post 8.03 EPS for the current fiscal year.
Maximus Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were given a dividend of $0.33 per share. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.32 annualized dividend and a yield of 2.4%. Maximus's dividend payout ratio is 19.50%.
Maximus Profile
(
Free Report)
Maximus, Inc NYSE: MMS is a provider of technology-enabled government services. The company partners with federal, state, provincial and local governments to administer public programs, improve service delivery and help agencies manage complex operational and administrative needs.
Its services include health and human services administration, employment and workforce support, program eligibility and enrollment, citizen engagement, customer contact centers, consulting and digital transformation.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.